Rizwan Romee, MD

Dr. Rizwan Romee is an Associate Professor of Medicine at Harvard Medical School and Director of the Haploidentical Donor Transplant Program at Dana-Farber Cancer Institute. A translational physician-scientist and oncologist, his research focuses on advancing NK cell–based immunotherapies for cancer. His laboratory employs innovative synthetic biology tools, including both CRISPR and non-CRISPR gene-editing technologies, to enhance NK cell anti-tumor function. He also leads the Dana-Farber NK Cell Therapeutics Initiative, driving the development of next-generation cellular therapies.